WAVE Life Sciences Ltd (NAS:WVE)
$ 5.74 0.22 (3.99%) Market Cap: 716.00 Mil Enterprise Value: 590.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

Q2 2021 WAVE Life Sciences Ltd Earnings Call Transcript

Aug 05, 2021 / 12:30PM GMT
Release Date Price: $6.03 (+8.65%)
Operator

Good morning, and welcome to the Wave Life Sciences Second Quarter 2021 Earnings Call. My name is Brandon, and I'll be your operator for today. (Operator Instructions). Please note this conference is being recorded.

I will now turn the call over to Kate Rausch, Head of Investor Relations at Wave Life Sciences. Kate, you may begin.

Kate Rausch
Wave Life Sciences Ltd. - Head of IR

Thank you, operator. Good morning, and thank you for joining us today to discuss our recent business progress and review Wave's second quarter 2021 operating results.

On the call with me today are Paul Bolno, Wave's President and Chief Executive Officer; Mike Panzara, Chief Medical Officer, Head of Therapeutics Discovery and Development; Paloma Giangrande, Vice President of Platform and Discovery Sciences and Biology; and Kyle Moran, Chief Financial Officer.

This morning, we issued a news release detailing our second quarter financial results and provide the business update. This news release and a slide presentation to accompany this webcast are available

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot